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Amavata is a crippling condition where simultaneously aggravated Vata and 
Ama associated with each other settles in Sandhis and produce Sandhishoola, 
Sandhishotha, Sparshaasahitwa, which is similar to Rheumatoid Arthritis. The 
present study has made an attempt to find an effective Ayurvedic treatment 
modality through Kshara Vasti and Vaitarana Vasti along with 
Shamanoushadhi. A total of 30 Patients were randomly divided in two groups 
with 15 patients in each group. In Group A, Kshara Vasti and in Group B, 
Vaitarana Vasti was given in Yoga Vasti schedule followed by Shamanoushadhi 
Simhanada Guggulu 500mg twice and Rasna Saptak Kwatha 40ml as Anupana 
for 45 days in both the groups with 1 month follow-up period.  
Both Group A and Group B provided highly significant results in all 
parameters of assessment but Kshara Vasti showed better improvement in the 
symptoms of the disease Amavata. 63.33% of patients got marked relief, 30% 
of patients got moderate relief. 56.66% of patients got marked relief in grip 
strength and 66.66% of the total number of patients got marked relief in 
tenderness.  
All the patients of both the groups responded well after Kshara Vasti and 
Vaitarana Vasti and the result were highly significant. The sustained affect of 
Vasti was very clearly evident after administration of Vasti along with 
Shamanoushadhi. Hence the modalities of our treatment can be recommended 
to all the patients of Amavata. 
 
INTRODUCTION 
Amavata is a condition where 
simultaneously aggravated Vata and Ama 
associated with each other settles in Sandhi and 
produce Sandhishoola, Sandhishotha, Sparshaa 
sahitwa, etc and ultimately stiffness of the joints, 
causing the temporary or permanent disability of 
joints and it hampers daily working capacity and 
runs a chronic course. In modern medicine a lot of 
similarity is seen with Rheumatoid arthritis. 
In early stages only the joint involvement 
can be seen with features like Angamarda, Aruchi, 
Alasya, Jwara and Angashoonata etc. But if it is not 
treated with systemic treatment procedures, then 
through the Madhyama Roga Marga, it will lead to 
cardiac damage and further complications like 
involvement of gastro- intestinal, cardiovascular, 
nervous, urinary and respiratory systems are also 
encountered.  
The prevalence rate is 0.5 - 1% of the adult, 
worldwide and in India the prevalence rate is 0.1 – 
0.4% with women affected 3 to 5 times as often as 
men. It is 3 times more common in smokers than 
non smokers particularly in men.[1] 
The Samshodhana and Samshamana 
treatment is commonly used in all the diseases. 
Samshodhana indicates the Dosha eliminating 
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process, whereas Samshamana gives knowledge 
regarding the palliative procedure of dosha inside 
the body. For Amavata, Acharya Chakradatta has 
given emphasis on a therapeutic programme in 
terms of Chikitsa sutra instead of single therapy for 
complete cure, without reoccurrence or to manage 
this disease. 
Langhanam Swednam Tiktam Deepnani Katuni Cha 
Virechnam Snehapanam Bastasyashama Maruthe 
Saindhavadya Anuvasasya KsharaVasti Prashasyate. 
(Cha. Da. 25/1) [2] 
According to Ayurvedic physiology Pitta and 
Kapha is dependent on Vata as it governs their 
functions. [3] Vasti eradicate morbid Vata from the 
root along with other Dosha and in addition it gives 
nutrients to the body tissue. [4] Therefore, Vasti 
therapy covers more than half of the treatment of 
all the disease[5], while some authors consider it as 
the complete remedy for all the ailments. Therefore, 
Vasti is considered the best remedy for morbid 
Vata, but according to Sushruta, it can also be used 
in Kaphaja and Pittaja disorders by using different 
ingredients[6]. 
For the present study on Amavata, as 
Shodhana therapy Kshara Vasti and Vaitarana Vasti 
has been chosen, which are mentioned in 
Chakradatta Niruha adhikara[7] and Vangasen 
Vastikarmadikara[8] respectively. Shaman therapy 
Simhanada Guggulu and Rasna Saptak Kwatha has 
been mentioned by Bhaishajya Ratnavali[9] which is 
common in both groups.   
Definition [10,11] 
Rheumatoid Arthritis (R.A.) is an 
autoimmune disease in which the immune system 
of the body attacks its own tissues i.e., here own 
cartilage and joint linings (synovial membrane) 
characterized by persistent inflammation of 
peripheral joints with associated systemic features. 
It is characterized by inflammation of the joints, 
which causes swelling, pain and loss of function.  
The incidence of occurrence is increasing 
now a day because of the altered food habits and 
modern life style. The onset is more frequent during 
4th and 5th decade of life with 80% of patients 
developing the disease between the ages of 35 to 50 
years. The incidence of Rheumatoid Arthritis is 3 
cases per 10,000 populations per annum. Onset is 
uncommon under the age of 15 and from then the 
incidence rises with the age until the age of 80. [12] 
Objectives 
1. To evaluate and compare the efficacy of Kshara 
Vasti and Vaitarana Vasti in the management of 
Amavata. 
2. To evaluate the efficacy of Simhanada Guggulu 
along with Rasna Saptak Kwatha. 
MATERIALS AND METHODS 
The following materials were used in the 
Clinical Trial 
1. Agnitundi Vati[13] 
2. Kshara Vasti[14] 
3. Vaitarana Vasti[15] 
4. Brihat Saindhavadi Taila[16] 
5. Simhanada Guggulu[17] 
6. Rasna Saptak Kwath[18] 
Methods of Collection of Data 
a. Patients attending OPD and IPD of PG 
Department of Kayachikitsa, Ayurveda 
Mahavidyalaya Hospital, Hubli was made and 
patients fulfilling the criteria of diagnosis as per 
the Performa were selected for the study. 
b. Clinical evaluation of patients was done by 
through history, physical examination, and 
laboratory tests. 
Inclusion Criteria 
1. The Amavata cases are diagnosed on the basis 
of signs & symptoms described in Ayurvedic 
classics. 
2. Patients of age group between 20-60 yrs, of 
both sexes.  
3. Disease chronicity less than five year duration. 
4. Patients fit for Vasti karma. 
Exclusion Criteria 
1. Uuncontrolled metabolic disorders such as 
Diabetes or Hypertension. 
2. Chronicity of disease more than 5 years with any 
joint deformity. 
3. Steroid dependent Patients, with cervical or 
Ankylosing spondylosis or S.L.E.  
4. Pregnancy 
Subjective Parameters 
1. Sandhi Shoola (pain) 
2. Sandhi Shotha (swelling) 




3. Sparshaasahitwa (tenderness) 
Sample Size 
 Minimum of 30 Patients diagnosed as 
Amavata were selected incidentally and randomly 
categorized into 2 groups consisting of 15 Patients 
in each group. 
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Group A 
Amapachana with Agnitundi Vati 250mg 
thrice daily half an hour before food with 
Ushnodaka as Anupana till Nirama Lakshanas seen. 
Kshara Vasti in Yoga Vasti was also scheduled for 8 
days. Simhanada Guggulu, 500mg tablet twice daily 
before food was given internally with Rasna Saptak 
Kwatha (48ml) as Anupana for 30 days. Pathya 
Ahara and Vihara were advised to all the Patients. 
The duration if the study was 38 days and there was 
follow up of 1 month. 
Group B 
Amapachana with Agnitundi Vati 250mg 
thrice daily half an hour before food with 
Ushnodaka as Anupana till Nirama Lakshanas seen. 
Vaitarana Vasti in Yoga Vasti was scheduled for 8 
days. Simhanada Guggulu, 500mg tablet twice daily 
before food was given internally with Rasna Saptak 
Kwatha (48ml) as Anupana for 30 days. 
Pathya Ahara and Vihara were advised to all 
the Patients same as group A. The duration if the 
study was 38 days and there was follow up of 1 
month. 
Table 1: Data Related to Administration of Vasti 
 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6  Day 7 Day 8 
Type of Vasti         
Dose         
Time of Administration         
Time of expulsion         
Retention time         
No. of evacuation         
Any other features         
OBSERVATIONS 
In the present study, 30 Patients were registered. 15 Patients were treated under group A, and 15 
Patients under group B. 
Table 2: Showing Age Wise Distribution of 30 Patients of Amavata 
Age Group A (n=15) % Group B (n=15) % Total % 
20-30 4 26.66% 1 6.66% 5 16.66% 
31-40 4 26.66% 7 46.66% 11 36.66% 
41-50 6 39.99% 5 33.33% 11 36.66% 
51-60 1 6.66% 2 13.33% 3 9.99% 
Table 3: Gender Wise Distribution of 30 Patients of Amavata 
Sex Group A (n=15) % Group B (n=15) % Total % 
Male 7 53.33% 5 33.33% 12 40.00% 
Female 8 46.66% 10 66.66% 18 60.00% 
Table 4: Religion Wise Distribution of 30 Patients of Amavata 
Religion Group A (n=15) % Group B (n=15) % Total % 
Hindu 8 53.33% 10 66.66% 18 60.00% 
Muslim 7 46.66% 5 33.33% 12 40.00% 
Others 0 - 0 - 0 - 
Table 5: Marital Status Wise Distribution of 30 Patients of Amavata 
Marital Status Group A (n=15) % Group B (n=15) % Total % 
Bachelor 2 13.33% 0 - 02 6.66% 
Married 13 86.66% 13 86.66% 26 86.66% 
Widow 0 - 2 13.33% 02 6.66% 
Divorcee 0 - 0 - 0 00% 
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Table 6: Educational Status Wise Distribution of 30 Patients of Amavata 
Education Group A (n=15) % Group B (n=15) % Total % 
Illiterate 1 6.66% 1 6.66% 02 6.66% 
Primary 4 26.66% 11 73.33% 15 49.99% 
Higher Secondary 6 39.99% 3 19.99% 09 29.99% 
Graduate 4 26.66% 0 - 04 13.33% 
Post graduate 0 - 0 - 0 00% 
Table 7: Occupation Wise Distribution of 30 Patients of Amavata 
Occupation Group A (n=15) % Group B (n=15) % Total % 
Laborer 2 13.33% 2 13.33% 04 13.33% 
Student 2 13.33% 0 - 02 6.66% 
Housewife 6 39.99% 9 59.99% 15 49.99% 
Teacher 1 6.66% 0 - 01 3.33% 
Office-worker 0 - 1 6.66% 01 3.33% 
Farmer 1 6.66% 2 13.33% 03 9.99% 
Business 3 19.99% 1 6.66% 04 13.33% 
Table 8: Vyasana Wise Distribution of 30 Patients of Amavata 
Vyasana Group A (n=15) % Group B (n=15) % Total % 
Alcoholism 2 13.33% 0 - 2 6.66% 
Tobacco 4 26.66% 5 33.33% 9 29.99% 
Supari/pan 0 - 2 13.33% 2 6.66% 
Smoking 3 19.99% 2 13.33% 5 16.66% 
No Vyasana 10 66.66% 9 59.99% 19 63.33% 
Table 9: Emotional Status Wise Distribution of 30 Patients of Amavata 
Emotional status Group A (n=15) % Group B (n=15) % Total % 
Tension 7 46.66% 11 73.33% 18 59.99% 
Anxiety 2 13.33% 0 - 02 6.66% 
Depression 1 6.66% 1 6.66% 02 6.66% 
Anger 0 - 0 - 0 - 
None of the above 5 33.33% 3 19.99% 08 26.66% 
Table 10: Cardinal Feature Wise Distribution of 30 Patients of Amavata 
Cardinal Feature Group A (n=15) % Group B (n=15) % Total % 
Sandhishoola 15 100% 15 100% 30 100% 
Sandhishotha 15 100% 15 100% 30 100% 
Sandhistabdata 15 100% 15 100% 30 100% 
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% Total % 
Angamarda 15 100% 15 100% 30 100% 
Shoonatanga 4 26.66% 4 26.66% 8 26.66% 
Shoola 12 79.99% 13 86.66% 25 83.33% 
Aruchi 11 73.33% 12 79.99% 23 76.66% 
Trushna 6 39.99% 7 46.66% 13 43.33% 
Alasya 8 53.33% 9 59.99% 17 56.66% 
Gaurava 7 46.66% 6 39.99% 13 43.33% 
Jwara 6 39.99% 5 33.33% 11 36.66% 
Apaka 3 19.99% 2 13.33% 5 16.66% 
Praseka 3 19.99% 3 19.99% 6 19.99% 
Utsahahani 5 33.33% 5 33.33% 10 33.33% 
Vairasya 3 19.99% 1 6.66% 4 13.33% 
Daha 2 13.33% 4 26.66% 6 19.99% 
Bahumootrata 0 - 2 13.33% 2 6.66% 
Kukshi katinya 0 - 1 6.66% 1 3.33% 
Kukshi shoola 2 13.33% 1 6.66% 3 9.99% 
Aanaha 1 6.66% 3 19.99% 4 13.33% 
Aantrakoojana 2 13.33% 2 13.33% 4 13.33% 
Chardi 4 26.66% 4 26.66% 8 26.66% 
Nidraviparyaya 10 53.33% 11 73.33% 21 69.99% 
Bhrama 0 - 0 - 0 - 
Murcha 0 - 0 - 0 - 
Hridgraha 5 33.33% 4 26.66% 9 29.99% 
Vitvibandha 13 86.66% 11 73.33% 24 79.99% 
Jadhya 1 6.66% 3 19.99% 4 13.33% 
Table 12: Distribution Based on Rheumatoid Factor of 30 Patients of Amavata 
R.A. factor Group A (n=15) % Group B (n=15) % Total % 
Positive 06 39.99% 06 39.99% 12 39.99% 
Negative 09 59.99% 09 59.99% 18 59.99% 







% Total % 
Upper extremities 
Shoulder 07 46.66% 05 33.33% 12 39.99% 
Elbow 09 59.99% 06 39.99% 15 49.99% 
Wrist 15 100% 14 93.33% 29 96.66% 
MCP 10 66.66% 09 59.99% 19 63.33% 
PIP 15 100% 15 100% 30 100% 
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Lower extremities 
Knee 06 39.99% 09 59.99% 15 49.99% 
Ankle 08 53.33% 11 73.33% 19 63.33% 
MTP 06 39.99% 04 26.66% 10 33.33% 
PIP 05 33.33% 06 39.99% 11 36.66% 
Others  0 - 0 - 0 - 







% Total % 
Upper extremities 
Shoulder 03 19.99% 02 13.33% 05 16.66% 
Elbow 04 26.66% 04 26.66% 08 26.66% 
Wrist 13 86.66% 11 73.33% 24 79.99% 
MCP 05 33.33% 06 39.99% 11 36.66% 
PIP 14 93.33% 12 79.99% 26 86.66% 
Lower extremities 
Knee 03 19.99% 08 53.33% 11 36.66% 
Ankle 07 46.66% 09 59.99% 16 53.33% 
MTP 03 19.99% 02 13.33% 05 16.66% 
PIP 05 33.33% 04 26.66% 09 29.99% 
Others  0 - 0 - 0 - 
Table 15: Distribution of Stiffness Based on Joint Involvement of 30 Patients of Amavata 
Joints Group A (n=15) % Group B (n=15) % Total % 
Upper extremities 
Shoulder 07 46.66% 05 33.33% 12 39.99% 
Elbow 09 59.99% 06 39.99% 15 49.99% 
Wrist 15 100% 14 93.33% 29 96.66% 
MCP 10 66.66% 09 59.99% 19 63.33% 
PIP 15 100% 15 100% 30 100% 
Lower extremities 
Knee 06 39.99% 09 59.99% 15 49.99% 
Ankle 08 53.33% 11 73.33% 19 63.33% 
MTP 06 39.99% 04 26.66% 10 33.33% 
PIP 05 33.33% 06 39.99% 11 36.66% 
Others 0 - 0 - 0 - 
Table 16: Distribution of Tenderness Based on Joint Involvement of 30 Patients of Amavata 
Joints Group A (n=15) % Group B (n=15) % Total % 
Upper extremities 
Shoulder 03 19.99% 02 13.33% 05 16.66% 
Elbow 04 26.66% 04 26.66% 08 26.66% 
Wrist 13 86.66% 11 73.33% 24 79.99% 
MCP 05 33.33% 06 39.99% 11 36.66% 
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PIP 14 93.33% 12 79.99% 26 86.66% 
Lower extremities 
Knee 03 19.99% 08 53.33% 11 36.66% 
Ankle 07 46.66% 09 59.99% 16 53.33% 
MTP 03 19.99% 02 13.33% 05 16.66% 
PIP 05 33.33% 04 26.66% 09 29.99% 
Others  0 - 0 - 0 - 
RESULTS 








SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 3.26 2.13 34.69 % 0.83 0.21 5.26 <0.001 Highly significant 
Group B (Vaitarana Vasti) 3.06 2.2 28.26 % 0.63 0.16 5.24 <0.001 Highly significant 








SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 2.13 0.46 78.25 % 0.72 0.18 8.91 <0.001 Highly significant 
Group B (Vaitarana Vasti) 2.2 0.53 75.75 % 0.72 0.18 8.91 <0.001 Highly significant 








SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 3.26 0.46 85.71 % 0.86 0.22 12.58 <0.001 Highly significant 
Group B (Vaitarana Vasti) 3.06 0.53 82.60 % 0.83 0.21 11.76 <0.001 Highly significant 








SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 2.13 1.53 28.12 % 0.50 0.13 4.58 <0.001 Highly significant 
Group B (Vaitarana Vasti) 2.13 1.66 21.87 % 0.51 0.13 3.5 <0.01 Significant 








SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 1.53 0.26 82.60 % 0.45 0.11 10.71 <0.001 Highly significant 
Group B (Vaitarana Vasti) 1.66 0.4 76.00 % 0.45 0.11 10.71 <0.001 Highly significant 








SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 2.13 0.26 87.50 % 0.74 0.19 9.72 <0.001 Highly significant 
Group B (Vaitarana Vasti) 2.13 0.4 81.25 % 0.70 0.18 9.53 <0.001 Highly significant 








SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 1.4 0.60 57.14 % 0.41 0.10 7.48 <0.001 Highly significant 
Group B (Vaitarana Vasti) 1.4 0.86 38.09 % 0.51 0.13 4.00 <0.01 Significant 
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SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 0.6 0.26 55.55% 0.48 0.12 2.64 <0.02 Significant 
Group B (Vaitarana Vasti) 0.86 0.46 46.15% 0.50 0.13 3.05 <0.01 Significant 








SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 1.4 0.26 80.95% 0.51 0.13 8.5 <0.001 Highly significant 
Group B (Vaitarana Vasti) 1.4 0.46 66.66% 0.45 0.11 7.89 <0.001 Highly significant 
Objective Parameters 








SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 2.33 1.26 45.71% 0.70 0.18 5.87 <0.001 Highly significant 
Group B (Vaitarana Vasti) 2.00 1.26 36.66% 0.45 0.11 6.2 <0.001 Highly significant 









SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 1.26 0.26 78.94 % 0.65 0.16 5.91 <0.001 Highly significant 
Group B (Vaitarana Vasti) 1.26 0.4 68.42 % 0.63 0.16 5.24 <0.001 Highly significant 








SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 2.33 0.26 88.57% 1.03 0.26 7.75 <0.001 Highly significant 
Group B (Vaitarana Vasti) 2.00 0.4 80.00% 0.82 0.21 7.48 <0.001 Highly significant 








SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 2.66 2.2 17.50% 0.51 0.13 3.5 <0.01 Significant 
Group B (Vaitarana Vasti) 2.4 2.06 13.88% 0.48 0.12 2.64 <0.02 Significant 








SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 2.2 0.53 75.75% 0.89 0.23 7.17 <0.001 Highly significant 
Group B (Vaitarana Vasti) 2.06 0.66 67.74% 0.63 0.16 8.57 <0.001 Highly significant 








SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 2.66 0.53 80.00% 0.74 0.19 11.11 <0.001 Highly significant 
Group B (Vaitarana Vasti) 2.4 0.66 72.22% 0.70 0.18 9.53 <0.001 Highly significant 
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SD SE ‘t’ P Remarks 
Group A (Kshara Vasti) 63.33 37.66 40.52% 4.95 1.27 20.07 <0.001 Highly significant 
Group B (Vaitarana Vasti) 69.66 46 33.97% 6.39 1.65 14.32 <0.001 Highly significant 
Table 33: Effect of Total Therapy on RA Factor 
RA factor B.T. % AT % 






















Table 34: Effect of Total Therapy on General Symptoms with respect to number of Patients 
General Symptoms 
Group A (n=15) Group B (n=15) 
n B.T A.T % of Relief n B.T A.T % of Relief 
Angamarda  15 15 6 60% 15 15 7 53.33% 
Shoonatanga 4 4 0 100% 4 4 0 100% 
Shoola 12 12 6 50% 13 13 7 46.15% 
Aruchi 11 11 0 100% 12 12 0 100% 
Trushna 6 6 0 100% 7 7 0 100% 
Alasya 8 8 2 75% 9 9 3 66.66% 
Gaurava 7 7 1 85.71% 6 6 2 66.66% 
Jwara 6 6 0 100% 5 5 0 100% 
Apaka 3 3 0 100% 2 2 0 100% 
Praseka 3 3 0 100% 3 3 0 100% 
Utsahahani 5 5 3 40% 5 5 3 40% 
Vairasya 3 3 0 100% 1 1 0 100% 
Daha 2 2 0 100% 4 4 0 100% 
Bahumootrata 0 0 0 - 2 2 0 100% 
Kukshi katinya 0 0 0 - 1 1 0 100% 
Kukshi shoola 2 2 0 100% 1 1 0 100% 
Aanaha 1 1 0 100% 3 3 0 100% 
Aantrakoojana 2 2 0 100% 2 2 0 100% 
Chardi 4 4 0 100% 4 4 0 100% 
Nidraviparyaya 10 10 3 70% 11 11 3 72.72% 
Bhrama 0 0 0 - 0 0 0 - 
Moorcha 0 0 0 - 0 0 0 - 
Hridgraha 5 5 2 60% 4 4 2 50% 
Vitvibandha 13 13 2 84.61% 11 11 2 81.81% 
Jadhya 1 1 0 100% 3 3 1 66.66% 
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Effect on the General Symptoms 
100% relief was observed in symptoms Aruchi and Trushna in both the groups. 84.61% and 81.81% 
relief was observed in the symptom Vitvibandha in Group A and Group B respectively. 85.71% and 66.66% 
relief was observed in the symptom Gaurava in Group A and Group B. 75% and 66.66% relief was observed 
in the symptom Alasya in Group A and Group B. 60% and 53.33% relief was observed in the symptom 
Angamarda in Group A and Group B, while least relief i.e., upto 50% was observed in the symptoms like 
Shoola. 
Comparative Efficacy of the Therapies in Group A and Group B 
Subjective Parameters 
Table 35: Comparative efficacy of Vasti between Group A and Group B 
Table 36: Comparative efficacy of Total Therapy between Group A and Group B 
Objective Parameters 
Table 37: Comparative efficacy of Vasti on Sparshaasahitwa between Group A and Group B 
Parameters of assessment No. of pts SD SE ‘t’ P Remarks 
Sparshaasahitwa 30 0.20 0.07 4.71 <0.001 Highly significant 
Table 38: Comparative efficacy of Total Therapy on Sparshaasahitwa between Group A and Group B 
Parameters of 
assessment 
No. of pts SD SE ‘t’ P Remarks 
Sparshaasahitwa 30 0.25 0.09 5.11 <0.001 Highly significant 
Table 39: Comparative efficacy of Vasti on Grip strength between Group A and Group B 
Parameters of 
assessment 
No. of pts SD SE ‘t’ P Remarks 
Grip strength 30 0.18 0.06 2.16 <0.05 Not significant 
Table 40: Comparative efficacy of Total Therapy on Grip strength between Group A and Group B 
Parameters of 
assessment 
No. of Pts SD SE ‘t’ P Remarks 
Grip strength 30 0.22 0.08 5.00 <0.001 Highly significant 
Table 41: Comparative efficacy of Total Therapy on E.S.R between Group A and Group B 
Parameters of 
assessment 
No. of Pts SD SE ‘t’ P Remarks 






Parameters of assessment No. of pts SD SE ‘t’ P Remarks 
Sandhi Shoola 30 0.22 0.08 3.37 <0.01 Significant 
Sandhi Shotha 30 0.18 0.06 2.33 <0.05 Not significant 
Stabdata 30 0.18 0.06 4.5 <0.001 Highly significant 
Parameters of assessment No. of pts SD SE ‘t’ P Remarks 
Sandhi Shoola 30 0.24 0.08 3.37 <0.01 Significant 
Sandhi Shotha 30 0.22 0.08 1.62 >0.10 Not significant 
Stabdata 30 0.18 0.06 3.33 <0.01 Significant 
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Table 42: Total Effect of the Therapy on 30 cases of Amavata under Group A and Group B on 
Subjective Parameters 
Group A (n=15) Group B (n=15) Total In % Relief Category  
0 0 0 - No Relief 
1 1 2 6.66% Mild Relief 
3 6 9 30.00% Moderate Relief 
11 8 19 63.33% Marked Relief 
Table 43: Total Effect of the Therapy on 15 cases of Amavata under Group A on Objective Parameters 
Grip strength In % Tenderness In % E.S.R In % Relief Category 
0 - 0 - 1 6.66% No Relief 
3 20% 2 13.33% 14 93.33% Mild Relief 
3 20% 2 13.33% 0 - Moderate Relief 
9 60% 11 73.33% 0 - Marked Relief 
Table 44: Total Effect of the Therapy on 15 cases of Amavata under Group B on Objective Parameters 
Grip strength In % Tenderness In % E.S.R In % Relief Category 
0 - 1 6.66% 3 20% No Relief 
6 40% 2 13.33% 12 80% Mild Relief 
1 6.66% 3 20% 0 - Moderate Relief 
8 53.33% 9 60% 0 - Marked Relief 
DISCUSSION 
Effect of Vasti in Sandhishoola 
Both Kshara Vasti and Vaitarana Vasti are 
effective in reducing the severity of Shoola in 
patients of Amavata. When the effects of two Vasti 
are compared, the Kshara Vasti Group showed 
statistically significant improvement in Sandhi 
shoola when compared with Vaitarana Vasti Group, 
with p value (p<0.01).  
The severity of pain was markedly 
decreased after Shamanoushadhi in both groups 
and result was statistically highly significant in 
Kshara Vasti Group (p<0.001) and Vaitarana Vasti 
Group (p<0.001).  
Both the Vasti are very effective, in reducing 
the severity of pain in patients of Amavata. But 
Kshara Vasti showed a better result than Vaitarana 
Vasti. 
Effect of Vasti in Sandhi Shotha 
The severity of Sandhishotha was markedly 
decreased after Vasti administration in both groups 
and result was statistically highly significant in 
Kshara Vasti Group (p<0.001) and statistically 
significant in Vaitarana Vasti Group (p<0.01) and 
hence Kshara Vasti and Vaitarana Vasti are effective 
in reducing the Sandhishotha in patients of 
Amavata. In the comparison, Kshara Vasti Group did 
not show any statistically significant improvement 
in Sandhishotha 
The severity of Sandhishotha was markedly 
decreased after Shamanoushadhi in both groups 
and result was statistically highly significant in 
Kshara Vasti Group (p<0.001) and in Vaitarana 
Vasti Group (p<0.001) and when the results are 
compared, Kshara Vasti Group did not show any 
statistically insignificant improvement. It can be 
concluded that both the groups are very effective in 
reducing the Shotha. 
Effect of Vasti in Stabdata 
The severity of Stabdata was markedly 
decreased after Vasti administration in both groups 
and result was statistically highly significant in 
Kshara Vasti Group (p<0.001) and statistically 
significant in Vaitarana Vasti Group (p<0.01). When 
the two Vasti are compared, the Kshara Vasti Group 
showed statistically highly significant improvement 
in Stabdata when compared with Vaitarana Vasti 
Group. 
Effect of Vasti in Sparsha Asahitwa 
The severity of Sparsha Asahitwa was 
markedly decreased after Vasti administration in 
both groups and result was statistically highly 
significant in Kshara Vasti Group (p<0.001) and in 
Vaitarana Vasti Group (p<0.01). In the comparison 
the Kshara Vasti Group showed statistically highly 
significant improvement in Sparsha Asahitwa. 
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The severity of Sparsha Asahitwa was 
markedly decreased just after Shamanoushadhi in 
both groups and result was statistically highly 
significant in Kshara Vasti Group (p<0.001) and in 
Vaitarana Vasti Group (p<0.001) and the Kshara 
Vasti Group showed statistically highly significant 
improvement in Sparsha Asahitwa, Hence Kshara 
Vasti showed a better improvement than Vaitarana 
Vasti. 
Effect of Vasti in Grip strength 
The Grip strength result was statistically 
significant in Kshara Vasti Group (p<0.01) and in 
Vaitarana Vasti Group (p<0.02).  
This means both Kshara Vasti and Vaitarana 
Vasti are effective in increasing the Grip strength in 
patients of Amavata, but when compared, the 
Kshara Vasti Group did not show any statistically 
significant improvement in Grip strength when 
compared with Vaitarana Vasti Group. 
The Grip strength was also analyzed after 
administration of Simhanada Guggulu with Rasna 
Saptak Kwatha as Anupana for 30 days following 
Vasti in both the groups. 
The Grip strength was markedly increased 
just after Shamanoushadhi in both groups and result 
was statistically highly significant in Kshara Vasti 
Group (p<0.001) and in Vaitarana Vasti Group 
(p<0.001). The Kshara Vasti Group showed 
statistically highly significant improvement in Grip 
strength when compared. 
Effect on Erythrocyte Sedimentation Rate after 
completion of total therapy 
40.52% improvement was observed in 
Group A while in Group B improvement observed 
was 33.97%.  
While comparing the two groups by 
unpaired ‘t’ test, the Kshara Vasti Group showed 
statistically highly significant improvement in the 
reduction of E.S.R values when compared with 
Vaitarana Vasti Group, with p value (p<0.001).  
CONCLUSION 
All the patients of both the groups 
responded well after Kshara Vasti and Vaitarana 
Vasti and the result were highly significant. The 
sustained affect of Vasti was very clearly evident 
after administration of Vasti along with 
Shamanoushadhi. Hence it can be concluded that the 
efficacy of Vasti in both groups was found to be 
satisfactory in spite of reducing dosage of 
Gomootra. Out of 30 Patients, 19 (63.33%) were 
markedly improved, 09 (30.00%) Moderately 
improved and lastly 02 (6%) were mildly improved 
after the completion of therapy in subjective 
parameters. 
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